流感疫苗市场基于(关键地区、市场参与者、规模和份额)- 到 2031 年的预测

  • Report Code : TIPRE00004070
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 209
Buy Now

2021年流感疫苗市场价值为74.7853亿美元,预计将增长到2028年将达到122.7249亿美元; 2022年至2028年复合年增长率为7.4%

流感是由流感病毒引起的传染性呼吸道感染。流感的症状包括发烧、咳嗽、肌肉和关节疼痛、头痛和严重虚弱。流感引起的疾病从轻微到严重不等,有时会导致死亡。根据世界卫生组织(WHO)的数据,2018年,因流感而住院的重症病例为3-500万例,而与流感相关的死亡人数约为29万至65万例。建议接种疫苗来预防流感感染。流感病毒流行在全球范围内的迅速蔓延推动了对开发有效流感疫苗的需求。强大的产品线是预测期内推动市场增长的关键因素。

流感疫苗市场根据疫苗类型、病毒类型、技术、给药途径、目标群体、和地理。按地域划分,市场大致分为北美、欧洲、亚太地区、中东和中东地区。非洲、南美和非洲中美洲。流感疫苗市场报告提供了对市场的见解和深入分析,强调市场趋势、技术进步、市场动态以及领先市场参与者的竞争分析。

战略见解

< h3>流感疫苗市场利润丰厚的地区

市场洞察

顶级市场参与者和政府增加投资以推动流感疫苗市场

世界各地的市场参与者和政府正在增加对疫苗开发和免疫的投资。例如,2021 年 3 月,赛诺菲宣布投资约 9.25 亿美元,在其位于多伦多和加拿大的现有基地建设一座新的疫苗生产工厂。对新工厂的投资将为赛诺菲的 FLUZONE 高剂量四价流感疫苗提供额外的抗原和填充能力,从而在未来几年增加加拿大、美国和欧洲的供应。

  • 2021年4月,联邦、省、市三级政府支持赛诺菲巴斯德在多伦多建设“端到端”流感疫苗工厂。合作伙伴将投资近 10 亿美元来启动和运行该网站,计划于 2027 年建成。总部位于巴黎的赛诺菲则将投资超过 5500 万美元,创造 165 个新的合格就业岗位,并维持另外 1,100 个就业岗位。联邦政府将投资5500万美元,安大略省政府将出资5500万美元,使该项目总耗资9.25亿美元。此外,赛诺菲还将在 8 年内每年投资至少 7900 万美元,资助加拿大的研发。
  • 2020 年 11 月,疫苗制造商 Seqirus 计划向澳大利亚一家重要企业投资 8 亿美元。疫苗生产中心。 Seqirus 表示,新工厂将位于墨尔本机场商业区的 Tullamarine,预计于 2026 年投产。该公司没有在声明中透露所需的平方米面积。
  • 2022 年 3 月,澳大利亚政府宣布投资 1 亿美元生产季节性流感疫苗。这项投资的目的是保护人们免受流感和 COVID-19 的侵害,尽量减少其对澳大利亚医疗保健的影响。
  • 2021 年 6 月,欧洲投资银行与澳大利亚签署了价值 3055 万美元的全球疫苗分销协议生物技术公司 Univercells 将在比利时新工厂大规模生产 COVID-19 疫苗。它帮助在世界各地建立了其他疫苗工厂。 2022年4月,央行向意大利生物医学研究公司IRBM提供了1527万美元贷款,用于扩大其疫苗产能并加强对冠状病毒和其他疾病的研究。

因此,全球顶级市场参与者和政府的投资正在提振流感疫苗市场。

疫苗类型洞察

根据疫苗类型,全球流感疫苗市场分为四价疫苗和三价疫苗。四价细分市场在 2021 年占据了更大的市场份额。预计该细分市场在预测期内将增长更快。不断增加的产品批准和不断增加的市场扩张产品发布是四价疫苗细分市场增长的主要驱动力。

流感疫苗市场(按疫苗类型) 2022年-2028年期间

病毒类型洞察

根据病毒类型,全球流感疫苗市场分为A型流感病毒和B型流感病毒。A型流感病毒细分市场2021 年将占据更大的市场份额。由于 A 型流感流行率不断上升,预计在预测期内该市场份额将增长更快。A 型流感病毒市场的增长归因于它是最常见的流感形式。它可以感染动物,尽管与此类流感相关的疾病更为常见。

产品批准和合作是流感疫苗市场参与者高度采用的策略。下面列出了近期的一些关键市场动态:

  • 2022 年 7 月,美国食品和药物管理局 (FDA) 批准了赛诺菲的疫苗许可申请针对即将到来的 2022-2023 年流感季节,包括 Fluzone 高剂量四价(流感疫苗)、Flublok 四价(流感疫苗)和 Fluzone 四价(流感疫苗)。此次批准是在 CDC 免疫实践咨询委员会 (ACIP) 针对 65 岁以上成年人的优先推荐(包括 Fluzone 高剂量四价和 Flublok 四价)之后推出的。
  • 2022 年 7 月,葛兰素史克宣布达成一项协议与加拿大政府合作开发大流行性和季节性流感疫苗,以帮助保护加拿大成人和儿童。该协议为期四年,截至 2026 年 3 月,包括在流感大流行时供应多达 8000 万剂 Arepanrix(佐剂大流行性流感疫苗),以及每年至少 400 万剂 Flulaval Tetra(季节性流感疫苗)。

由于大流行期间对流感疫苗的需求不断增加,预计 COVID-19 大流行将推动全球流感疫苗市场的增长。根据美国疾病控制与预防中心2021年11月公布的数据,2020年9月至12月美国流感疫苗总体接种量增加了9.0%,其中青少年和成人接种的剂量比2018年9月至12月和2019年更多. 

流感疫苗–市场细分

根据疫苗类型、病毒类型、技术、给药途径、目标群体和地理位置对全球流感疫苗市场进行分析。根据疫苗类型,市场分为四价疫苗和三价疫苗。根据病毒类型,市场分为甲型流感病毒和乙型流感病毒。根据技术,市场分为基于鸡蛋和基于细胞的流感病毒。根据给药途径,市场分为注射剂和鼻喷雾剂。根据目标群体,市场可分为婴儿、儿童、成人和老年人。按地域划分,流感疫苗市场分为北美、欧洲、亚太地区、中东和北美。非洲、南美和非洲中美洲。

公司简介

Moderna, Inc.; SEQIRUS;赛诺菲;葛兰素史克公司;华兰生物工程股份有限公司;紧急生物解决方案公司;三菱化学集团公司;印度血清研究所列兵。有限公司;迈兰公司;和阿斯利康是流感疫苗市场上的主要公司。这些公司正在采取产品创新战略,以满足全球不断变化的客户需求,从而使他们能够在全球流感疫苗市场上保持品牌声誉

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Which segment by vaccine type led the influenza vaccines market?

The quadrivalent segment held the larger share of the market in the global influenza vaccines market contributing a market share of 88.36% in 2022.

Which region is projected to be the fastest-growing region in the global influenza vaccines market?

The Asia Pacific is expected to be the fastest-growing region in the influenza vaccines market over the forecast period due to growing investments from international players in China and India, increasing disposable income, and influenza cases in these regions will show promising growth in the influenza vaccines market.

What is the estimated influenza vaccines market size in 2021?

The influenza vaccines market is estimated to be valued at US$ 7,478.53 million in 2021.

What are the growth estimates for the influenza vaccines market till 2028?

The influenza vaccines market is expected to be valued at US$ 12,272.49 million in 2028.

What is the market CAGR value of the influenza vaccines market during the forecast period?

The CAGR value of the influenza vaccines market during the forecasted period of 2022-2028 is 7.4%.

Who are the major players in the influenza vaccines market across the globe?

The influenza vaccines market majorly consists of the players, such as Moderna, Inc.; SEQIRUS; Sanofi; GlasoSmithKline plc; Hualan Biological Engineering Inc.; Emergent Biosolutions Inc.; Mitsubishi Chemical Group Corporation; Serum Institute of India Pvt. Ltd; Mylan N. V.; and AstraZeneca

What are the driving factors for the global influenza vaccines market across the world?

The factors that are driving the growth of the influenza vaccines market are increase in government support to promote influenza vaccination and increasing investment by top market players and governments.

What are influenza vaccines?

Influenza virus causes flu which is a contagious respiratory illness that infects nose, throat and lungs. It can mild or severe and sometimes may lead to death. Flu vaccination every year can help in preventing flu. However, this can be deadly, especially in high-risk groups. Aged population, pregnant women and people with one or more chronic disease or with weak immune systems are at high risk. Influenza vaccines/flu shots protect against the four influenza viruses’ subtypes that are most common. Most of the influenza vaccines are “flu shots” given with a needle, usually in the arm, but nasal spray flu vaccine are also available.

The List of Companies - Influenza Vaccines Market

  1. Moderna, Inc.
  2. SEQIRUS
  3. Sanofi
  4. GlaxoSmithKline plc.
  5. Hualan Biological Engineering Inc.
  6. Emergent BioSolutions Inc.
  7. Mitsubishi Chemical Group Corporation
  8. Serum Institute of India Pvt. Ltd
  9. MYLAN N.V.
  10. AstraZeneca

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports